BTI
DXCM icon

Blue Trust Inc’s DexCom DXCM Stock Holding History

Blue Trust Inc’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.8K Sell
428
-18
-4% -$1.2K ﹤0.01% 1547
2026
Q1 		$28K Sell
446
-69
-13% -$4.8K ﹤0.01% 1537
2025
Q4 		$34.2K Sell
515
-199
-28% -$12.9K ﹤0.01% 1487
2025
Q3 		$48K Buy
714
+348
+95% +$27.5K ﹤0.01% 1430
2025
Q2 		$31.9K Buy
366
+55
+18% +$4.31K ﹤0.01% 1558
2025
Q1 		$21.2K Sell
311
-27
-8% -$2.2K ﹤0.01% 1630
2024
Q4 		$26.3K Sell
338
-1,441
-81% -$107K ﹤0.01% 1529
2024
Q3 		$202K Buy
1,779
+898
+102% +$73.7K ﹤0.01% 846
2024
Q2 		$122K Buy
881
+496
+129% +$62.7K ﹤0.01% 890
2024
Q1 		$53.4K Sell
385
-136
-26% -$17.1K ﹤0.01% 895
2023
Q4 		$49K Buy
521
+51
+11% +$5.21K ﹤0.01% 946
2023
Q3 		$60K Buy
470
+33
+8% +$3.72K ﹤0.01% 787
2023
Q2 		$50K Sell
437
-225
-34% -$27.2K ﹤0.01% 692
2023
Q1 		$75K Buy
662
+108
+19% +$12.1K ﹤0.01% 862
2022
Q4 		$45K Buy
554
+189
+52% +$20.8K ﹤0.01% 967
2022
Q3 		$27K Buy
365
+327
+861% +$27.7K ﹤0.01% 965
2022
Q2 		$19K Buy
+38
New +$3.47K ﹤0.01% 967

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Blue Trust Inc's DXCM Position: Q2 2026 in Review

Blue Trust Inc reduced its DexCom (DXCM) stake by 4% in Q2 2026, selling an estimated $1.2K and leaving 428 shares worth $28.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1547.

Blue Trust Inc first reported a position in DXCM in Q2 2022 and has held it in 17 quarters since. The position peaked at $202K in Q3 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Blue Trust Inc held 428 shares of DexCom worth $28.8K as of Q2 2026.
  • Blue Trust Inc sold 18 DexCom shares in Q2 2026, an estimated $1.2K.
  • DexCom made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1547 holding.
  • Blue Trust Inc first reported a position in DexCom in Q2 2022 and has held it in 17 quarters since.
  • Blue Trust Inc's DexCom position peaked at $202K in Q3 2024.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.